Home › Funds › Citigroup Inc › PLX

Citigroup Inc position in PLX

PROTALIX BIOTHERAPEUTICS INC · Health Care

Latest position (Q2 2026)34.69K sh
Reported value held$80.83K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd

Quarter by quarter

QuarterSharesValueChange
Q3 2021 2.50M $2.53M New
Q4 2021 2.50M $2.33M Hold
Q1 2022 300 $0 Reduce
Q2 2022 2.50M $2.46M Add
Q3 2022 2.50M $2.45M Hold
Q4 2022 2.50M $2.58M Hold
Q1 2023 2.50M $3.07M Hold
Q2 2023 18.44K $36.89K Reduce
Q3 2023 1.89K $3.14K Reduce
Q4 2023 11.55K $20.56K Add
Q1 2024 12.73K $16.04K Add
Q2 2024 1.31K $1.53K Reduce
Q4 2024 632 $1.19K New
Q1 2025 2.29K $5.87K Add
Q2 2025 24.76K $36.64K Add
Q3 2025 6.61K $14.68K Reduce
Q4 2025 1.63K $2.94K Reduce
Q1 2026 2.96K $6.42K Add
Q2 2026 34.69K $80.83K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding PLX

All PLX fund holders →